By the same authors

From the same journal

From the same journal

An evaluation of the feasibility, cost and value of information of a multicentre randomised controlled trial of intravenous immunoglobulin for sepsis (severe sepsis and septic shock): incorporating a systematic review, meta-analysis and value of information analysis

Research output: Contribution to journalArticle

Author(s)

  • M O Soares
  • N J Welton
  • D A Harrison
  • P Peura
  • M Shankar- Hari
  • S E Harvey
  • J J Madan
  • A E Ades
  • S J Palmer
  • K M Rowan

Department/unit(s)

Publication details

JournalHealth technology assessment
DatePublished - Feb 2012
Issue number7
Volume16
Number of pages186
Pages (from-to)1-186
Original languageEnglish

Abstract

Sepsis is a syndrome characterised by a systemic inflammatory response to infection that leads to rapid acute organ failure and potentially rapid decline to death. Intravenous immunoglobulin (IVIG), a blood product derived from human donor blood, has been proposed as an adjuvant therapy for sepsis.

Discover related content

Find related publications, people, projects, datasets and more using interactive charts.

View graph of relations